Unlocking a New Era in Membrane Protein Research: Nanodiscs Empower AI Drug Discovery and Cryo-EM Analysis

In recent years, the rapid development of AI-driven drug discovery (AI-based drug discovery) and Cryo-EM (cryo-electron [...]

Optimizing GPCR Expression and Purification: Enhancing Synthetic Nanodisc Technology with Multiple Tag Strategies

1. About Synthetic Nanodisc The lipid composition of traditional membrane scaffold protein (MSP) nanodiscs often [...]

Synthetic Nanodisc, A Promising Solution for “Undruggable” Membrane Proteins

NPY Receptor Family: “New Targets” and “Old Challenges” in Disease Treatment

In the drug development efforts targeting complex diseases such as neuropsychiatric disorders, metabolic dysregulation, and [...]

An Invitation|Welcome to meet DIMA BIOTECH in Boston in May

DIMA BIOTECH will showcase over 5,000+ in-stock lead mAbs and 500+ in-stock Nanodisc at 2025 [...]

Who Dominates the Billion-Dollar Market for Systemic Lupus Erythematosus Treatment?

According to a blog released by market intelligence provider Future Market Insights, Inc. (FMI) on [...]

TRPV1: An Important Target for Pain Treatment

Do you remember the temperature and touch receptor TRPV1 that made American scientists David Julius [...]

MC4R: A Niche Target in the Weight Loss Drug Market

On July 16, 2024, Dr. Roger Cone, co-founder of the preclinical biotech company Courage, published [...]

The glucagon receptor (GCGR)：A Key Target in Glucose Metabolism

On June 25, 2024, at the 2024 American Diabetes Association (ADA) Scientific Sessions, Suzhou Innovent Biologics [...]

GLP1R Target: Not Just for Blood Sugar Control and Weight Loss, but a Potential Breakthrough for Anti-Nausea in Weight Loss Medications

Currently, the most popular GLP1-based monotherapy, Semaglutide, controls blood sugar by promoting insulin secretion and [...]